| Basics |
|
Invivyd, Inc.
|
| IPO Date: |
August 6, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$437.4M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.08 | 5.15%
|
| Avg Daily Range (30 D): |
$0.08 | 5.34%
|
| Avg Daily Range (90 D): |
$0.05 | 4.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.95M |
| Avg Daily Volume (30 D): |
5.04M |
| Avg Daily Volume (90 D): |
4.71M |
| Trade Size |
| Avg Trade Size (Sh.): |
308 |
| Avg Trade Size (Sh.) (30 D): |
450 |
| Avg Trade Size (Sh.) (90 D): |
406 |
| Institutional Trades |
| Total Inst.Trades: |
41 |
| Avg Inst. Trade: |
$3.17M |
| Avg Inst. Trade (30 D): |
$9.73M |
| Avg Inst. Trade (90 D): |
$5.79M |
| Avg Inst. Trade Volume: |
1.54M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3M |
| Avg Closing Trade (30 D): |
$.79M |
| Avg Closing Trade (90 D): |
$2.6M |
| Avg Closing Volume: |
2.41M |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.12
|
$-.14
|
$-.15
|
|
Diluted EPS
|
$-.12
|
$-.14
|
$-.15
|
|
Revenue
|
$ 11.79M
|
$ 11.3M
|
$ 13.82M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -14.66M
|
$ -16.29M
|
$ -18.44M
|
|
Operating Income / Loss
|
$ -15.06M
|
$ -16.92M
|
$ -19.23M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -13.18M
|
$ -21.26M
|
$ -37.53M
|
|
PE Ratio
|
|
|
|
|
|
|